CRAC Channel
Read More about this categoryShow Less
The Ca2+ release-activated Ca2+ (CRAC) channel is a highly Ca2+-selective store-operated channel expressed in T cells, mast cells, and various other tissues. CRAC channels regulate critical cellular processes such as gene expression, motility, and the secretion of inflammatory mediators. The identification of Orai1, a key subunit of the CRAC channel pore, and STIM1, the endoplasmic reticulum (ER) Ca2+ sensor, have provided the tools to illuminate the mechanisms of regulation and the pore properties of CRAC channels. Opening of CRAC channels enables the refilling of ER Ca2+ stores and sustains long-lasting Ca2+ oscillations and plateau signals, critical for the proliferation of T cells and production of cytokines following antigenic stimulation.
Products Related to CRAC Channel(14)
- GC30361CRAC intermediate 2CAS: 123066-64-8Purity: >99.50%
CRAC intermediate 2 is a intermediate compound for CRAC inhibitor synthesis, extracted from patent WO 2013059666A1.
- GC31852CRAC intermediate 1CAS: 1249343-86-9Purity: >98.00%
CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors, detailed information can be found in Patent WO 2010122089 A1, intermediate 9.
- GC37658SOCE inhibitor 1CAS: 2169316-15-6Purity: >99.50%
SOCE inhibitor 1 is a store-operated calcium entry (SOCE) inhibitor with an IC50 of 4.4 μM.
- GC60327RO2959 hydrochlorideCAS: 1219927-22-6Purity: >98%
RO2959 hydrochloride is a potent and selective CRAC channel inhibitor with an IC50 of 402 nM.
- GC61248RO2959 monohydrochlorideCAS: 2309172-44-7Purity: >99.00%
RO2959 monohydrochloride is a potent and selective CRAC channel inhibitor with an IC50 of 402 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11683 | MRS 1845 | 544478-19-5 | >98.00% | |
store-operated Ca2+ channels blocker | ||||
| GC14665 | YM 58483 | 223499-30-7 | >98.00% | |
YM 58483 is a pyrazole-derived inhibitor of CRAC channels that inhibits Ca 2+ signals with an IC 50 value of 100nM. | ||||
| GC19107 | CM-4620 | 1713240-67-5 | >98.00% | |
CM-4620 is a selective inhibitor of Orai channels, with IC 50 =0.119μM for Orai1 and 0.895μM for Orai2. | ||||
| GC30361 | CRAC intermediate 2 | 123066-64-8 | >99.50% | |
CRAC intermediate 2 is a intermediate compound for CRAC inhibitor synthesis, extracted from patent WO 2013059666A1. | ||||
| GC31680 | GSK-5498A | 1253186-49-0 | >98.00% | |
GSK-5498A is a selective CARC channel inhibitor (IC50: 1 μM). | ||||
| GC31852 | CRAC intermediate 1 | 1249343-86-9 | >98.00% | |
CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors, detailed information can be found in Patent WO 2010122089 A1, intermediate 9. | ||||
| GC33472 | Synta66 | 835904-51-3 | >99.00% | |
Synta66 is an inhibitor of store-operated calcium entry channel Orai, which forms the pore of the CRAC channel, and used for the research of neurological disease. | ||||
| GC37658 | SOCE inhibitor 1 | 2169316-15-6 | >99.50% | |
SOCE inhibitor 1 is a store-operated calcium entry (SOCE) inhibitor with an IC50 of 4.4 μM. | ||||
| GC50179 | 5J 4 | 827001-82-1 | >98% | |
CRAC channel blocker; anti-inflammatory | ||||
| GC60327 | RO2959 hydrochloride | 1219927-22-6 | >98% | |
RO2959 hydrochloride is a potent and selective CRAC channel inhibitor with an IC50 of 402 nM. | ||||
| GC61248 | RO2959 monohydrochloride | 2309172-44-7 | >99.00% | |
RO2959 monohydrochloride is a potent and selective CRAC channel inhibitor with an IC50 of 402 nM. | ||||
| GC65999 | piCRAC-1 | 2418049-54-2 | >98% | |
piCRAC-1 is a potent, photoinducible Ca2+ release-activated Ca2+ (CRAC) channel inhibitor. piCRAC-1 alleviates thrombocytopenia and hemorrhage. | ||||
| GC79519 | SKF-96365 | 162849-90-3 | >99.50% | |
SKF-96365 is a TRPC channel antagonist and store-operated calcium entry ( SOCE ) inhibitor. | ||||
| GN10809 | Tanshinone IIA sulfonate sodium | 69659-80-9 | >98.00% | |
